V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20166287 | 20063629 | 1.63 | 52.05 | Neo-adjuvant (N) | 2017-08-27 | 2017-09-11 | ECX | 2 | N | CAPECITABINE + GEMCITABINE | 101318038 |
| 20166288 | 20063630 | 1.7 | 84.8 | Palliative (P) | 2019-11-22 | 2019-12-03 | ECX | N | N | ECX | 100858789 |
| 20166289 | 20063631 | 1.7 | 68.3 | Palliative (P) | null | 2017-06-21 | CAPECITABINE + GEMCITABINE | null | N | CAPECITABINE + GEMCITABINE | 101420622 |
| 20166291 | 20063632 | 1.6 | 79.4 | Palliative (P) | 2018-09-12 | 2018-09-19 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100535230 |
| 20166301 | 20063633 | 1.68 | 72.7 | Palliative (P) | 2017-10-29 | 2017-10-29 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 101773910 |
| 20166311 | 20063634 | 1.78 | 88 | Neo-adjuvant (N) | 2016-05-22 | 2016-05-22 | ECX | 2 | Y | ECX | 100216852 |
| 20166315 | 20063635 | 1.78 | 78.4 | Palliative (P) | 2016-11-09 | 2016-11-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100140808 |
| 20166321 | 20063636 | 1.66 | 78.6 | Neo-adjuvant (N) | 2018-02-11 | 2018-02-11 | ECX | N | N | ECX | 100273659 |
| 20166325 | 20063637 | 1.76 | 90 | Curative (C) | 2017-11-22 | 2017-11-22 | ECX | N | N | ECX | 100021150 |
| 20166326 | 20063638 | 1.68 | 51.5 | Adjuvant (A) | 2018-03-18 | 2018-04-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101416960 |
| 20166331 | 20063639 | 1.65 | 48 | Neo-adjuvant (N) | 2016-03-09 | 2016-03-22 | Gemcitabine + Capecitabine | 02 | N | ECX | 101701595 |
| 20166333 | 20063640 | 1.85 | 67.5 | Adjuvant (A) | 2019-12-07 | 2019-12-13 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101050342 |
| 20166337 | 20063641 | 1.65 | 64.9 | null | 2018-11-23 | 2018-11-25 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100303345 |
| 20166338 | 20063642 | 1.72 | 71.6 | null | 2018-01-28 | 2018-02-10 | ECX | N | N | ECX | 100400083 |
| 20166343 | 20063643 | 1.67 | 73.2 | Palliative (P) | 2017-04-18 | 2017-05-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100302637 |
| 20166344 | 20063644 | 1.62 | 68.55 | Curative (C) | 2018-05-20 | 2018-05-28 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100331394 |
| 20166351 | 20063645 | null | 89 | Palliative (P) | 2016-09-04 | 2016-09-10 | ECX | 02 | N | ECX | 101367559 |
| 20166355 | 20063646 | 1.62 | 76.8 | Neo-adjuvant (N) | 2018-04-15 | 2018-04-20 | ECX | N | Y | ECX | 101865194 |
| 20166363 | 20063647 | null | null | Neo-adjuvant (N) | 2019-04-07 | 2019-04-07 | ECX | 02 | N | ECX | 100688760 |
| 20166369 | 20063648 | 1.5 | 67.5 | Palliative (P) | 2016-11-09 | 2016-12-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100269080 |
| 20166372 | 20063649 | 1.93 | 63.1 | Adjuvant (A) | 2016-06-08 | 2016-06-12 | ECX | 02 | N | ECX | 101082331 |
| 20166376 | 20063650 | 1.63 | 80 | Curative (C) | 2016-09-11 | 2016-10-06 | ECX | N | N | ECX | 100506648 |
| 20166392 | 20063651 | 1.49 | 75 | 03 | 2018-10-02 | 2018-10-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100977363 |
| 20166399 | 20063652 | 1.78 | 71 | Curative (C) | 2018-11-14 | 2018-11-18 | ECX | 2 | N | ECX | 101351376 |
| 20166412 | 20063653 | 1.58 | 78.05 | Neo-adjuvant (N) | 2018-09-23 | 2018-09-23 | ECX | N | N | ECX | 101444098 |
| 20166417 | 20063654 | 1.69 | 84 | 03 | 2016-08-15 | 2016-08-20 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 101018336 |
| 20166425 | 20063655 | 1.77 | 66.4 | Palliative (P) | 2017-04-20 | 2017-04-21 | ECX | 02 | N | ECX | 100827750 |
| 20166428 | 20063656 | 1.62 | 59.4 | Neo-adjuvant (N) | 2016-04-13 | 2016-05-03 | ECX | N | N | ECX | 101509403 |
| 20166430 | 20063657 | 1.76 | 72.7 | Adjuvant (A) | 2017-09-20 | 2017-09-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100168652 |
| 20166438 | 20063658 | 1.59 | 99.1 | Adjuvant (A) | 2016-05-27 | 2016-06-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101540789 |
| 20166440 | 20063659 | 1.77 | 51.1 | Adjuvant (A) | 2017-10-20 | 2017-10-22 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101125181 |
| 20166444 | 20063660 | 1.82 | 64.35 | Neo-adjuvant (N) | 2017-11-27 | 2017-11-28 | ECX | 2 | N | ECX | 100253997 |
| 20166445 | 20063661 | 1.47 | 76.8 | Neo-adjuvant (N) | 2016-05-31 | 2016-06-11 | ECX | N | Y | ECX | 100190388 |
| 20166456 | 20063662 | 1.74 | 47.8 | Adjuvant (A) | 2017-08-23 | 2017-08-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101481021 |
| 20166458 | 20063663 | 1.62 | 72.9 | Neo-adjuvant (N) | 2018-03-05 | 2018-03-20 | ECX | N | N | ECX | 101421455 |
| 20166459 | 20063664 | 1.5 | 86.1 | Palliative (P) | 2017-10-19 | 2017-11-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100360013 |
| 20166463 | 20063665 | 1.7 | 78.9 | Adjuvant (A) | 2018-04-17 | 2018-06-04 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100263818 |
| 20166465 | 20063666 | 1.73 | 58.4 | Neo-adjuvant (N) | 2017-08-15 | 2017-08-17 | ECX | 02 | N | ECX | 100005819 |
| 20166467 | 20063667 | 1.77 | 90.15 | Neo-adjuvant (N) | 2019-11-13 | 2019-11-13 | ECX | 02 | N | ECX | 101653868 |
| 20166468 | 20063668 | 1.75 | 97.8 | Adjuvant (A) | 2016-05-09 | 2016-05-22 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101224853 |
| 20166471 | 20063669 | null | null | Adjuvant (A) | 2017-04-11 | 2017-04-23 | ECX | N | N | ECX | 101055198 |
| 20166472 | 20063670 | 1.69 | 83.8 | Adjuvant (A) | 2020-01-16 | 2020-02-13 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101679682 |
| 20166473 | 20063671 | 1.63 | 84.4 | Palliative (P) | 2016-10-17 | 2016-10-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100751577 |
| 20166485 | 20063672 | 1.72 | 77.3 | Neo-adjuvant (N) | 2019-10-19 | 2019-10-19 | ECX | N | N | ECX | 101726123 |
| 20166490 | 20063673 | 1.51 | 61 | Palliative (P) | 2016-06-02 | 2016-06-06 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101499528 |
| 20166491 | 20063674 | 1.83 | 99 | Adjuvant (A) | 2019-08-06 | 2019-08-12 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100316628 |
| 20166496 | 20063675 | 1.77 | 78.2 | Palliative (P) | 2016-02-25 | 2016-02-25 | ECX | N | N | ECX | 100418101 |
| 20166497 | 20063676 | 1.5 | 50 | Palliative (P) | 2019-06-08 | 2019-06-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101603993 |
| 20166504 | 20063677 | 1.63 | 106.55 | Palliative (P) | 2019-04-06 | 2019-04-18 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101820552 |
| 20166505 | 20063678 | 1.74 | 93.3 | Neo-adjuvant (N) | 2017-07-15 | 2017-07-18 | ECX | N | N | ECX | 100127343 |